Tom Schoenherr
Fortune : 6 M $ au 30/09/2026
Fortune : 6 M $ au 30/09/2026
Tom Schoenherr is Chief Executive Officer-Diagnostics at Tempus AI, Inc. since 2026.
From 2017 to 2025, Mr. Schoenherr was Chief Executive Officer at Ambry Genetics Corp.
from 2021 to 2025.
Education includes undergraduate studies at Michigan State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TEMPUS AI, INC. CLASS A 0,04 % | 25/09/2026 | 76 740 ( 0,04 % ) | 6 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TEMPUS AI, INC. | Corporate Officer/Principal | 01/02/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
Ambry Genetics Corp.
Ambry Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Provides genetic testing services | Directeur Général | 01/01/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambry Genetics Corp.
Ambry Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Provides genetic testing services | Commercial Services |
Tempus AI, Inc.
Tempus AI, Inc. Packaged SoftwareTechnology Services Develops AI platform for clinical and molecular data testing | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national